Skip to main content
Show full summary

Lord Clement-Jones to ask Her Majesty's Government what incentives, if any, they plan to introduce to ensure that, following Brexit, firms continue to develop intellectual property in the UK, including for paediatric products and orphan medicines; and whether, in so doing, they will take into account any recommendations arising out of the European Commission’s current analysis of intellectual property incentives for the pharmaceutical industry.  HL2897

Question HL2897: tabled on 6 November 2017 and due for answer by 20 November 2017

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Clement-Jones to ask Her Majesty's Government what incentives, if any, they plan to introduce to ensure that, following Brexit, firms continue to develop intellectual property in the UK, including for paediatric products and orphan medicines; and whether, in so doing, they will take into account any recommendations arising out of the European Commission’s current analysis of intellectual property incentives for the pharmaceutical industry.  HL2897
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.